Internal Medicine, Hematology & Oncology · Orlando, FL
NPI
1871591990
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1400 S Orange Ave
Orlando, FL, 32806
Phone (407) 648-3800
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
701 services
Medicare patients, 2024
330
Average age 73
Drug cost, 2024
$9.8M
2,109 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Said M Baidas was code 99214 (office e&m - established), 279 times for 152 patients. In total Said M Baidas billed 701 services in 14 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 279 | 152 | $67.06 | $19K |
| 99213 Office E&M - Established | Facility | 144 | 122 | $42.24 | $6,083 |
| 99232 Hospital E&M - Subsequent | Facility | 64 | 19 | $61.43 | $3,932 |
| 99215 Office E&M - Established | Facility | 40 | 28 | $112.56 | $4,502 |
| 99231 Hospital E&M - Subsequent | Facility | 34 | 14 | $38.85 | $1,321 |
| 99204 Office E&M - New | Facility | 31 | 31 | $93.12 | $2,887 |
| 99203 Office E&M - New | Facility | 25 | 25 | $57.13 | $1,428 |
| 99213 Office E&M - Established | Office | 21 | 20 | $55.12 | $1,158 |
| 99221 Hospital E&M - Initial | Facility | 20 | 19 | $65.27 | $1,305 |
| 99233 Hospital E&M - Subsequent | Facility | 14 | 13 | $92.04 | $1,289 |
| 99214 Office E&M - Established | Office | 12 | 11 | $84.16 | $1,010 |
By year: 2022 $45K for 693 services; 2023 $44K for 684 services; 2024 $45K for 701 services.
Medicare prescription drug claims, 2024
In 2024, the drug Said M Baidas prescribed most often to Medicare patients was Eliquis (Apixaban), with 352 prescriptions and refills. In total Said M Baidas wrote 2,109 Medicare prescriptions that cost $9.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 352 | 497 | 73 | $288K |
| Acyclovir Generic | 209 | 357 | 56 | $2,625 |
| Pomalyst Pomalidomide | 106 | 106 | 18 | $2.4M |
| Hydroxyurea Generic | 89 | 163 | 19 | $1,775 |
| Revlimid Lenalidomide | 87 | 87 | 17 | $1.5M |
| Tamoxifen Citrate Generic | 79 | 231 | 21 | $2,832 |
| Anastrozole Generic | 78 | 235 | 25 | $1,775 |
| Deferasirox Generic | 78 | 78 | Under 11 | $25K |
| Imbruvica Ibrutinib | 76 | 84 | Under 11 | $1.2M |
| Xarelto Rivaroxaban | 69 | 105 | 12 | $57K |
| Dexamethasone Generic | 67 | 90 | 20 | $819 |
| Letrozole Generic | 61 | 129 | 14 | $1,201 |
| Pantoprazole Sodium Generic | 56 | 88 | 14 | $334 |
| Imatinib Mesylate Generic | 54 | 54 | Under 11 | $59K |
| Jakafi Ruxolitinib Phosphate | 54 | 54 | Under 11 | $959K |
Brand drugs: 960 claims; generic drugs: 1,149 claims; opioid claims: 31.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Said M Baidas were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.